Seven patients were observed for 28 days after taking the AG - 221 , a new drug they were developing . These patients had AML that have evolved blow up or fail to respond to four different types of treatment .
Of the seven patients , six showed a good response to a given drug . Three patients declared no longer showed symptoms alias gets cancer remission . Two patients otherwise free of symptoms but not yet fully recovered , which means the leukemia has come out of spinal cord blood platelets but they have not returned to normal .
(see also: pakan burung top song)
" I am very excited to know what happens to these patients , who showed a response , " said study leader Dr . Eytan Stein from Memorial Sloan Kettering Cancer Center in New York .
AML is a cancer of the blood type of acute leukemia is the most common in adults . Cancer that attacks the blood and the spinal cord and develop very quickly if not treated immediately . AG - 221 drug , said Stein , working with the target gene mutation found in 10 to 15 percent of patients with AML . However, he cautioned that the data he can still in very early .
" If the result has been confirmed ( in a further larger trials ) , the result would be very interesting , " Stein said as quoted by Reuters on Wednesday ( 09/04/2014 ) .
Patients in the study Stein got 30 or 50 milligrams of AG - 221 , twice in one day . Stein and other researchers did not expect that the results will be visible even if the new drug is given in the lowest dose . He also noted that there are no side effects seen in patients . It is assessed Stein is very different when compared with chemotherapy .